Askeby, Denmark

Peter Arctander

This inventor holds 1 USPTO granted patent. Top assignee: Exiqon A/s. Active years: 2016.


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Arctander

Introduction

Peter Arctander is a notable inventor based in Askeby, Denmark. He has made significant contributions to the field of molecular biology, particularly in the detection and analysis of nucleic acids. His work has implications for understanding diseases, including cancer.

Latest Patents

Peter Arctander holds a patent for "Oligonucleotides useful for detecting and analyzing nucleic acids of interest." This invention features improved nucleic acids and methods for expression profiling of mRNAs. It also includes identifying and profiling particular mRNA splice variants, as well as detecting mutations, deletions, or duplications of specific exons or other splice variants. These advancements are crucial for analyzing biological samples or patient samples, especially in the context of diseases such as cancer. He has 1 patent to his name.

Career Highlights

Peter Arctander is associated with Exiqon A/S, a company that focuses on providing innovative solutions in the field of molecular biology. His work at Exiqon has allowed him to contribute to the development of tools that enhance the understanding of genetic information.

Collaborations

Some of his notable coworkers include Carsten Alsbo and Niels Tommerup. Their collaborative efforts have further advanced the research and development of molecular biology tools.

Conclusion

Peter Arctander's contributions to the field of molecular biology through his innovative patents and work at Exiqon A/S highlight the importance of research in understanding genetic diseases. His advancements in nucleic acid analysis continue to pave the way for future discoveries.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…